BEAT - BioTelemetry, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
1.84B
Enterprise Value 3
1.99B
Trailing P/E
50.58
Forward P/E 1
25.65
PEG Ratio (5 yr expected) 1
1.14
Price/Sales (ttm)
4.50
Price/Book (mrq)
5.10
Enterprise Value/Revenue 3
4.88
Enterprise Value/EBITDA 6
18.06

Trading Information

Stock Price History

Beta (5Y Monthly) 1.30
52-Week Change 3-17.78%
S&P500 52-Week Change 325.98%
52 Week High 380.92
52 Week Low 337.07
50-Day Moving Average 347.90
200-Day Moving Average 343.79

Share Statistics

Avg Vol (3 month) 3257.93k
Avg Vol (10 day) 3313.96k
Shares Outstanding 533.99M
Float 29.92M
% Held by Insiders 12.76%
% Held by Institutions 194.03%
Shares Short (Dec 30, 2019) 42.68M
Short Ratio (Dec 30, 2019) 411.76
Short % of Float (Dec 30, 2019) 49.46%
Short % of Shares Outstanding (Dec 30, 2019) 47.89%
Shares Short (prior month Nov 28, 2019) 42.48M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 9.45%
Operating Margin (ttm)17.12%

Management Effectiveness

Return on Assets (ttm)7.00%
Return on Equity (ttm)11.78%

Income Statement

Revenue (ttm)408.98M
Revenue Per Share (ttm)12.12
Quarterly Revenue Growth (yoy)11.20%
Gross Profit (ttm)228.26M
EBITDA 110.47M
Net Income Avi to Common (ttm)38.66M
Diluted EPS (ttm)1.07
Quarterly Earnings Growth (yoy)-48.20%

Balance Sheet

Total Cash (mrq)61.57M
Total Cash Per Share (mrq)1.81
Total Debt (mrq)216.92M
Total Debt/Equity (mrq)60.10
Current Ratio (mrq)2.46
Book Value Per Share (mrq)10.62

Cash Flow Statement

Operating Cash Flow (ttm)81.06M
Levered Free Cash Flow (ttm)42.49M